Grant Pickering, CHIEF EXECUTIVE OFFICER at Vaxcyte, Inc. (PCVX), sold 30,000 shares at $78.65 ($2.4M) on 2024-08-23, disclosed to the SEC on 2024-08-26.
Scheduled sale ($2.4M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.65 | 6,686 | $526K | 22.2% |
| 2 | $78.65 | 6,686 | $526K | 22.2% |
| 3 | $79.25 | 8,314 | $659K | 27.8% |
| 4 | $79.25 | 8,314 | $659K | 27.8% |
| Total | $78.98 avg | 30,000 | $2.4M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $1.2M | — | Filing → |
| PCVX | SELL | 2024-12-10 | $401K | — | Filing → |
| PCVX | SELL | 2024-12-03 | $2.8M | — | Filing → |